1-3 of 3
Sarah Kelley
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Measurable Residual Disease Status By Clonotypic Mass Spectrometry with Easym Assay Predicts Outcomes Following Autologous Hematopoietic Cell Transplant in Multiple Myeloma

Michael Slade, Abir Khaled, Mark Fiala, Zac McDonald, Mariya Liyasova, Julie Fortier, Mark Zaydman, Sarah Kelley, Zachary David Crees, Mark A. Schroeder, Keith Stockerl-Goldstein, Liqiang Yang, Ravi Vij
Journal: Blood
Blood (2023) 142 (Supplement 1): 3354.
https://doi.org/10.1182/blood-2023-172440
Published: 2023
Journal Articles

Clonotypic Mass Spectrometry with Easym Assay for Detection of Measurable Residual Disease in Multiple Myeloma

Michael J Slade, Abir Khalid, Mark A Fiala, Mariya Liyasova, Mark A Zaydman, Zac McDonald, Julie M Fortier, Sarah Kelley, Zachary D. Crees, Mark A. Schroeder, Keith E Stockerl-Goldstein, Liqiang Yang, Ravi Vij
Journal: Blood
Blood (2022) 140 (Supplement 1): 4376–4377.
https://doi.org/10.1182/blood-2022-155582
Published: 2022
Journal Articles

Financial Toxicity Among Patients with Multiple Myeloma

Alice Silberstein, Mark A. Fiala, Sarah Kelley, Mark A. Schroeder, Keith E. Stockerl-Goldstein, Ravi Vij
Journal: Blood
Blood (2021) 138 (Supplement 1): 4027.
https://doi.org/10.1182/blood-2021-153653
Published: 2021